ACHP Letter to FDA on Direct-to-Consumer Drug Advertising

March 30, 2026 The Alliance of Community Health Plans (ACHP) sent a letter to FDA Commissioner Dr. Marty Makary calling for increased oversight of direct-to-consumer prescription drug advertising. Lax enforcement in recent decades has caused these ads to blossom, flooding consumers with misleading content and driving up drug spending. ACHP calls on the FDA to … Continued

ACHP Supports the Biosimilar Red Tape Elimination Act

ACHP letter backing H.R. 5526/S. 1954, which would eliminate the separate interchangeability designation for FDA-approved biosimilars, reducing costs and expanding patient access to lower-priced biologic therapies.

icon-arrow
client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo
icon-arrow